Litigation Details for AstraZeneca AB v. Alembic Pharmaceuticals Ltd. (D. Del. 2022)

AstraZeneca AB v. Alembic Pharmaceuticals Ltd. (D. Del. 2022)

Docket		Date Filed	2022-09-16
Court	District Court, D. Delaware	Date Terminated	2022-12-29
Cause	35:1 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Patents	10,300,065
Link to Docket	External link to docket

Details for AstraZeneca AB v. Alembic Pharmaceuticals Ltd. (D. Del. 2022)

Date Filed	Document No.	Description	Snippet	Link To Document
2022-09-16	1	Complaint	22 Page 2 of 13 PageID #: 2 Patent No. 10,300,065 (“the ’065 patent”), that is listed in the Approved… This is an action for patent infringement arising under the patent laws of the United States, … PATENT-IN-SUIT 35. On May 28, 2019, the U.S. Patent and Trademark Office… the ’065 patent are valid and enforceable. AstraZeneca AB is the owner of the ’065 patent by assignment…Book-listed patents protecting BRILINTA® and its use, including the ’934 and ’065 patents.	External link to document
2022-12-29	13	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,300,065. (Attachments: # 1… 30 December 2022 1:22-cv-01216 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2022-09-16	4	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,300,065. (lam) (Entered: 09…HOLDER OF PATENT OR TRADEMARK TRADEMARK NO. OR TRADEMARK 1 10,300,065 …following G Trademarks or G Patents. ( G the patent action involves 35 U.S.C. § 292.): DOCKET…PHARMACEUTICALS, INC. PATENT OR DATE OF PATENT … G Other Pleading PATENT OR DATE OF PATENT	External link to document